Gabapentin is a medication primarily known for its use in treating epilepsy and neuropathic pain. Its ownership is complex, involving the original patent holder and subsequent generic manufacturers.
What was the original patent for gabapentin?
Gabapentin was initially developed and patented by Parke-Davis, which was later acquired by Warner-Lambert, and subsequently by Pfizer [1]. The patent covered the synthesis and use of gabapentin.
When did the gabapentin patent expire?
The original patents for gabapentin expired in the late 2000s, allowing for the introduction of generic versions of the drug. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals [2].
Who makes generic gabapentin now?
Following the expiration of the original patents, numerous pharmaceutical companies began manufacturing and marketing generic versions of gabapentin. These include companies such as Teva Pharmaceuticals, Mylan (now Viatris), and Sandoz, among many others [3]. The availability of generics has significantly increased competition and reduced the cost of the medication.
How does gabapentin work?
Gabapentin is an anticonvulsant and analgesic medication. While its exact mechanism of action is not fully understood, it is thought to work by affecting calcium channels in the brain and modulating the release of certain neurotransmitters, which can help to reduce abnormal electrical activity and nerve pain [4].
What conditions is gabapentin used to treat?
Gabapentin is FDA-approved for the treatment of partial seizures in adults and children [4]. It is also widely prescribed off-label for a range of conditions, including:
* Nerve pain (neuropathic pain), such as postherpetic neuralgia (pain after shingles) [4]
* Restless legs syndrome [5]
* Anxiety disorders [6]
* Fibromyalgia [7]
Are there other drugs like gabapentin?
Yes, gabapentin belongs to a class of drugs known as gabapentinoids, which also includes pregabalin (Lyrica). While they share some similarities in their mechanisms of action and therapeutic uses, there are also differences in their pharmacokinetic profiles, potency, and approved indications [8].
---
Sources:
1. https://www.pfizer.com/
2. https://drugpatentwatch.com/
3. https://www.goodrx.com/gabapentin/generic-vs-brand
4. https://www.ncbi.nlm.nih.gov/books/NBK544447/
5. https://www.mayoclinic.org/diseases-conditions/restless-legs-syndrome/diagnosis-treatment/drc-20351047
6. https://www.verywellmind.com/gabapentin-for-anxiety-5075075
7. https://www.rheumatology.org/content/fibromyalgia-diagnosis-and-treatment
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449327/